Andreia Gomes

Andreia Gomes

Auto-generated profile, based on publicly available information

Andreia Gomes

Institute of Nuclear Sciences Applied To Health - University of Coimbra, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Atherosclerosis
Verified
Journal Article
Closed access
MOManuel Oliveira-Santos
Manuel Oliveira-Santos
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
RSRodolfo Silva
Rodolfo Silva
AGAndreia Gomes
Andreia Gomes
NCNuno Chichorro
Nuno Chichorro
MJMaria Vidigal João
Maria Vidigal João

1 October 2018 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
MJMaria Vidigal João
Maria Vidigal João
MOManuel Oliveira-Santos
Manuel Oliveira-Santos
RSRodolfo Silva
Rodolfo Silva
AGAndreia Gomes
Andreia Gomes
NFNuno Ferreira
Nuno Ferreira
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco

1 February 2020 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
MOManuel Oliveira-Santos
Manuel Oliveira-Santos
GMGearoid McMahon
Gearoid McMahon
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
RSRodolfo Silva
Rodolfo Silva
AGAndreia Gomes
Andreia Gomes
MJMaria Vidigal João
Maria Vidigal João
Objectives: Atherosclerotic plaque molecular imaging with 18F-sodium fluoride (NaF) PET with computed tomography (PET-CT) may identify active unstable microcalcification. We sought to explore renal arteries calcification activity in a group of high cardiovascular (CV) risk subjects without manifest CV disease. Methods: High CV risk hypertensive individuals from a single centre were prospectively scanned with 18F-NaF-PET-CT in major vascular territories. Renal arterial wall activity was retrospectively analysed and expressed as the ratio between maximum standard uptake value in the lesion and mean blood pool activity in the superior vena cava [tissue-to-background ratio (TBR)]. We explored renal artery wall 18F-NaF activity’s association to CV risk factors and renal function. Results: Mean age was 64 ± 8.6 years, 56% male, 96% Caucasian and 24% had chronic kidney disease (CKD) (n = 25). Six individuals (24%) showed renal artery wall radiotracer uptake (TBR 1.4 ± 0.4); these subjects were heavier, had higher triglycerides, high-sensitivity C-reactive protein and predicted CV risk (SCORE) compared to the remaining cohort (P < 0.05 for all comparisons). There was a trend toward higher 18F-NaF uptake in other major vessels and increased thoracic fat volume in subjects with renal artery wall uptake. Glomerular filtration rate (GFR) was lower in subjects with positive renal plaques (93.0 ± 29.7 vs. 65.0 ± 19.7 ml/min, P = 0.04). Renal artery radiotracer uptake and eGFR were inversely correlated (r = −0.42, P = 0.04). Conclusion: In a high CV risk group without manifest CV disease, higher renal artery wall 18F-NaF activity is associated with superior predicted CV risk and lower GFR.

3 April 2020 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
Sandra AnjoSandra Anjo
Sandra Anjo
PSPatrícia Valério dos Santos
Patrícia Valério dos Santos
LRLuiza Rosado
Luiza Rosado
GBGraça Baltazar
Graça Baltazar
IBInes Baldeiras
Ines Baldeiras
Bruno ManadasBruno Manadas
Bruno Manadas
Background: The identification of circulating biomarkers that closely correlate with Parkinson’s Disease (PD) has failed several times in the past. Nevertheless, in this pilot study, a translational approach was conducted, allowing the evaluation of the plasma levels of two mitochondrial-related proteins, whose combination leads to a robust model with potential diagnostic value to discriminate the PD patients from matched controls. Methods: The proposed translational approach was initiated by the analysis of secretomes from cells cultured under control or well-defined oxidative stress conditions, followed by the identification of proteins related to PD pathologic mechanisms that were altered between the two states. This pipeline was further translated into the analysis of undepleted plasma samples from 28 control and 31 PD patients. Results: From the secretome analysis, several mitochondria-related proteins were found to be differentially released between control and stress conditions and to be able to distinguish the two secretomes. Similarly, two mitochondrial-related proteins were found to be significantly changed in a PD cohort compared to matched controls. Moreover, a linear discriminant model with potential diagnostic value to discriminate PD patients was obtained using the combination of these two proteins. Both proteins are associated with apoptotic mitochondrial changes, which may correspond to potential indicators of cell death. Moreover, one of these proteins, the VPS35 protein, was reported in plasma for the first time, and its quantification was only possible due to its previous identification in the secretome analysis. Conclusions: In this work, an adaptation of a translational pipeline for biomarker selection was presented and transposed to neurological diseases, in the present case Parkinson’s Disease. The novelty and success of this pilot study may arise from the combination of: i) a translational research pipeline, where plasma samples are interrogated using knowledge previously obtained from the evaluation of cells’ secretome under oxidative stress; ii) the combined used of statistical analysis and an informed selection of candidates based on their link with relevant disease mechanisms, and iii) the use of SWATH-MS, an untargeted MS method that allows a complete record of the analyzed samples and a targeted data extraction of the quantitative values of proteins previously identified.

28 April 2020 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
CDCélia Domingues
Célia Domingues
MJMaria Vidigal João
Maria Vidigal João
RSRodolfo Silva
Rodolfo Silva
MOManuel Oliveira-Santos
Manuel Oliveira-Santos
AGAndreia Gomes
Andreia Gomes
AAAntero Abrunhosa
Antero Abrunhosa

1 December 2025 in Meta-Radiology
Verified
Journal Article
Open access
PMPatrícia Marques-Alves
Patrícia Marques-Alves
MJMaria Vidigal João
Maria Vidigal João
RSRodolfo Silva
Rodolfo Silva
JRJoão Borges Rosa
João Borges Rosa
AGAndreia Gomes
Andreia Gomes
LGLino Gonçalves
Lino Gonçalves